Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00335764
Brief Title: Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

First Submitted : June 8, 2006
First Submitted that Met QC Criteria : June 8, 2006
First Posted : June 12, 2006 (Estimate)

Results First Submitted : August 16, 2017
Results First Submitted that Met QC Criteria : May 31, 2018
Results First Posted : July 2, 2018

Last Update Submitted that Met QC Criteria : May 31, 2018
Last Update Posted : July 2, 2018